by Alex Jani: interviewing visionaries of healthcare innovation
<p>The X-Health.show brings to you brilliant minds behind programming living cells, tech that detects pre-term delivery in seconds, brain-computer interface or apps that employ AI to match you, your disease with the best treatment. <br><br>For the eXtra Health of the future.<br><br>You’ll meet visionaries from Switzerland who push the boundaries of healthcare. <br><br>Engineers who teamed up with doctors, scientists turned CEOs, doctors programming AI-powered apps, researchers who abandoned university labs to improve your health.<br><br>You’ll hear stories of promising startups founders and successful serial entrepreneurs. <br><br>Patients who imagine a better way.<br><br>You’ll <br>learn about new disease treatments<br>understand how AI-driven health tech can improve your life <br>grasp the way founders innovate <br>or even, get inspired to jumpstart innovation at your company.<br><br>Luckily, the X-Health.show is based in Switzerland, the most innovative country in the world according to World Intellectual Property Organization. For the 12th consecutive year. No wonder when the abundance of funds for innovation meets the ability to commercialize the discoveries.<br><br>With notable research institutions situated nearby top pharmaceutical companies, there’s more to expect. More medical innovations, break-through femtech, life changing biotech, developments in digital health, genetic engineering, and wearables, such as smart ring, blood pressure measurement on your wrist or ECG in your pyjama.<br><br><br>Follow the show to meet these amazing innovators.</p>
Language
🇺🇲
Publishing Since
4/22/2023
Email Addresses
0 available
Phone Numbers
0 available
December 10, 2024
Giovanna Dipasquale shares the benefits of personalized radiotherapy for breast cancer patients, reducing pain, discomfort, and radiation session times with a 3D-printed breast shell.
December 3, 2024
Dr. Tristan Vouga, a robotic design engineer with a Ph.D. in wearable robotics, discusses how TWIICE's modular exoskeleton enables people with paraplegia to stand and walk again after training.
November 28, 2024
Dr. Ivana Domljanovic, a Swiss nanotechnology expert, discusses developing a rapid blood test for breast cancer detection using DNA origami and microRNAs at Xemperia, a Swiss startup aiming to reduce breast cancer mortality.
Matt Pillar
STAT
Jason Calacanis
PHD Ventures
Ancient Health Podcast
Andreessen Horowitz
Dave Asprey
Science Magazine
Dr. Michael Gervais
Springer Nature Limited
Peter Attia, MD
Science Friday and WNYC Studios
The Wall Street Journal
Dr. Mark Hyman
Lex Fridman
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.